Journal article
Scientific Advances in Thoracic Oncology 2016
RA Soo, ECA Stone, KM Cummings, JR Jett, JK Field, HJM Groen, JL Mulshine, Y Yatabe, L Bubendorf, S Dacic, R Rami-Porta, FC Detterbeck, E Lim, H Asamura, J Donington, HA Wakelee, YL Wu, K Higgins, S Senan, B Solomon Show all
Journal of Thoracic Oncology | ELSEVIER SCIENCE INC | Published : 2017
Abstract
Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma..
View full abstractGrants
Awarded by American Cancer Society
Funding Acknowledgements
This work was funded in part through a Lung Cancer Foundation of America-International Association for the Study of Lung Cancer grant (to Dr. Costa), an American Cancer Society grant RSG 11-186 (to Dr. Costa), and National Cancer Institute grant CA090578 (to Dr. Costa). The CONVERT trial was funded by a Cancer Research UK grant (Dr. Faivre-Finn). The Editors would like to acknowledge all coauthors for providing a succinct and expert commentary in a swift manner and thank Managing Editor Murry Wynes for outstanding editorial assistance.